Evidence map›Paper›PMID 26863439›Full record

ArticlePLoS pathogens2016

The Hepatitis C Virus-Induced Membranous Web and Associated Nuclear Transport Machinery Limit Access of Pattern Recognition Receptors to Viral Replication Sites.

Christopher J Neufeldt, Michael A Joyce, Nicholas Van Buuren, Aviad Levin, Karla Kirkegaard, Michael Gale, D Lorne J Tyrrell, Richard W Wozniak

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Host Subcellular Organelles: Targets of Viral Manipulation.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Article
  11. Classification, replication, and transcription ofFrontiers in microbiology · 2023
    Review
  12. Article
  13. WTAP Targets the METTL3 mJournal of virology · 2022
    Article
  14. Article
  15. A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy function.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Christopher J NeufeldtDepartment of Cell Biology University of Alberta, Edmonton, Alberta, Canada.
Michael A JoyceDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
Nicholas Van BuurenDepartment of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.
Aviad LevinDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
Karla KirkegaardDepartment of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.
Michael GaleDepartment of Immunology, University of Washington, Seattle, Washington, United States of America.
D Lorne J TyrrellDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
Richard W WozniakDepartment of Cell Biology University of Alberta, Edmonton, Alberta, Canada.
University of Alberta · CAStanford University · USUniversity of Washington · US

Funding

Translational Incubator CoreU19AI109662 · NIAID · STANFORD UNIVERSITY · PI GLENN, JEFFREY S · 2014 to 2019
$28.6M
West Nile Virus and host control of innate defensesU19AI083019 · NIAID · UNIVERSITY OF WASHINGTON · PI GALE, MICHAEL · 2009 to 2018
$22.5M
The Host Response to Hepatitis C VirusR01AI118916 · NIAID · UNIVERSITY OF WASHINGTON · PI GALE, MICHAEL · 2016 to 2020
$2.5M
Canadian Institutes of Health Research MOP 106502Canadian Institutes of Health Research MOP 126142NIAID NIH HHS R01 AI118916NIAID NIH HHS U19 AI083019NIAID NIH HHS U19 AI109662
6 · The paper itself

Abstract

Hepatitis C virus (HCV) is a positive-strand RNA virus of the Flaviviridae family and a major cause of liver disease worldwide. HCV replicates in the cytoplasm, and the synthesis of viral proteins induces extensive rearrangements of host cell membranes producing structures, collectively termed the membranous web (MW). The MW contains the sites of viral replication and assembly, and we have identified distinct membrane fractions derived from HCV-infected cells that contain replication and assembly complexes enriched for viral RNA and infectious virus, respectively. The complex membrane structure of the MW is thought to protect the viral genome limiting its interactions with cytoplasmic pattern recognition receptors (PRRs) and thereby preventing activation of cellular innate immune responses. Here we show that PRRs, including RIG-I and MDA5, and ribosomes are excluded from viral replication and assembly centers within the MW. Furthermore, we present evidence that components of the nuclear transport machinery regulate access of proteins to MW compartments. We show that the restricted assess of RIG-I to the MW can be overcome by the addition of a nuclear localization signal sequence, and that expression of a NLS-RIG-I construct leads to increased immune activation and the inhibition of viral replication.

Indexed as

Active Transport, Cell NucleusCell LineCell MembraneHepacivirusHumansNuclear Localization SignalsReceptors, Pattern RecognitionRNA, ViralViral ProteinsVirus ReplicationNuclear Localization SignalsReceptors, Pattern RecognitionRNA, ViralViral Proteins

Identifiers

PMID26863439
PMCPMC4749181
OpenAlexW2252997710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.